These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32863209)
1. Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice. Ye J; Wang Y; Xu Y; Wang Z; Liu L; Wang M; Ye D; Zhang J; Yang Z; Lin Y; Ji Q; Wan J Redox Biol; 2020 Sep; 36():101636. PubMed ID: 32863209 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice. Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093 [TBL] [Abstract][Full Text] [Related]
3. IL-27p28 knockout aggravates Doxorubicin-induced cardiotoxicity by regulating Macrophage polarization. Feng Y; Ji Q; Ye D; Pan H; Lu X; Gan L; Wang M; Liu J; Xu Y; Zhang J; Zhao M; Xu S; Yin Z; Pan W; Wei C; Liu M; Wan J; Ye J Biochem Pharmacol; 2023 Apr; 210():115469. PubMed ID: 36868324 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 knockout reverses macrophage differentiation imbalance and alleviates cardiac dysfunction in aging mice. Wang Y; Zhu S; Wei W; Tu Y; Chen C; Song J; Li J; Wang C; Xu Z; Sun S Aging (Albany NY); 2020 Oct; 12(20):20184-20197. PubMed ID: 33099539 [TBL] [Abstract][Full Text] [Related]
5. Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice. Zhang J; Yang Z; Liang Z; Wang M; Hu C; Chang C; Shi L; Ji Q; Liu L Mediators Inflamm; 2021; 2021():6611085. PubMed ID: 33958974 [TBL] [Abstract][Full Text] [Related]
6. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112 [TBL] [Abstract][Full Text] [Related]
7. Anti-interleukin-5-neutralizing antibody attenuates caradiac injury and cadiac dysfunction by aggravating the inflammatory response in doxorubicin-treated mice. Xian D; Zhan Y; Yang Z; Fan C; Liu L; Lin Y Cell Biol Int; 2020 Jun; 44(6):1363-1372. PubMed ID: 32125042 [TBL] [Abstract][Full Text] [Related]
8. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132 [TBL] [Abstract][Full Text] [Related]
9. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells. Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 deficiency affects lipopolysaccharide-induced macrophage-related oxidative stress and myocardial cell apoptosis via the Nrf2 pathway both in vivo and in vitro. Liang Z; Pan F; Yang Z; Wang M; Hu C; Shi L; Ji Q; Liu L Biofactors; 2021 Jul; 47(4):674-685. PubMed ID: 33979459 [TBL] [Abstract][Full Text] [Related]
11. Losmapimod ameliorates doxorubicin-induced cardiotoxicity through attenuating senescence and inflammatory pathways. Dabour MS; Abdelgawad IY; Sadaf B; Daniel MR; Grant MKO; Seelig D; Zordoky BN Biomed Pharmacother; 2024 Oct; 179():117288. PubMed ID: 39146767 [TBL] [Abstract][Full Text] [Related]
13. Rhein Alleviates Doxorubicin-Induced Myocardial Injury by Inhibiting the p38 MAPK/HSP90/c-Jun/c-Fos Pathway-Mediated Apoptosis. Chen Y; Tu Y; Cao J; Wang Y; Ren Y Cardiovasc Toxicol; 2024 Nov; 24(11):1139-1150. PubMed ID: 39240427 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126 [TBL] [Abstract][Full Text] [Related]
15. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C. Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856 [TBL] [Abstract][Full Text] [Related]
16. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148 [TBL] [Abstract][Full Text] [Related]
17. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice. Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843 [TBL] [Abstract][Full Text] [Related]
18. TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy. Guo Z; Tang N; Liu FY; Yang Z; Ma SQ; An P; Wu HM; Fan D; Tang QZ J Cell Mol Med; 2020 Sep; 24(18):10913-10923. PubMed ID: 33140921 [TBL] [Abstract][Full Text] [Related]
19. IKKα-STAT3-S727 axis: a novel mechanism in DOX-induced cardiomyopathy. Chen G; Yao Y; Liu Y; Zhang R; Wen C; Zhou Q; Xu Y; Wang W; Jiang H; Tao Z; Chen W; Qiu Z; Chen X Cell Mol Life Sci; 2024 Sep; 81(1):406. PubMed ID: 39287798 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-5 deletion promotes sepsis-induced M1 macrophage differentiation, deteriorates cardiac dysfunction, and exacerbates cardiac injury via the NF-κB p65 pathway in mice. Liang W; Li J; Bai C; Chen Y; Li Y; Huang G; Wang X Biofactors; 2020 Nov; 46(6):1006-1017. PubMed ID: 33043521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]